This article is educational and is not medical advice.
SHBG (sex hormone-binding globulin) is a glycoprotein made mainly by liver cells that binds sex steroids in the bloodstream and controls how much of them can reach tissue.
It binds dihydrotestosterone most tightly, testosterone strongly, and estradiol more loosely. Albumin binds the same hormones weakly and in bulk. Whatever is left unbound is the free fraction, and that free fraction is small relative to the total. Because SHBG holds hormone in a tightly bound reservoir, a change in SHBG changes the balance between what is stored and what is immediately available, even when the total amount of hormone in the blood has not moved at all.
SHBG is not a passive container. Its production is regulated at the level of gene transcription in liver cells, and the transcription factor HNF-4 alpha sits at the centre of that control, which is why hepatic metabolic state, thyroid hormone and sex steroids all shift SHBG output in fairly predictable directions[1]. SHBG may also have actions of its own at cell membranes, though that part of the biology is less settled than its carrier role.
The practical consequence is simple. SHBG behaves like a sensitive readout of what the liver is doing metabolically, and raising it almost always means changing the inputs the liver is responding to.
SHBG matters because it sets the free fraction, so two people with identical total testosterone can have very different amounts of usable hormone.
When SHBG is low, less hormone is bound. Total testosterone can read at the bottom of the range or below it while free testosterone stays reasonable, which is a common pattern in men carrying excess visceral fat. When SHBG is high, the reverse happens. Total testosterone can look comfortable while free testosterone sits low, and the symptoms a person reports may line up with the free value rather than the total.
In women, low SHBG raises the free androgen index and is a recognised feature of the metabolic and androgenic picture seen in polycystic ovary syndrome, which is part of why SHBG has been proposed as an early marker in that setting[2].
There is a measurement caveat worth knowing. Free testosterone is usually calculated from total testosterone, SHBG and albumin rather than measured directly, so variability between SHBG assays carries straight through into the calculated free value[3]. A free testosterone figure is only as stable as the SHBG number behind it.
So SHBG is not a side note on a hormone panel. It is the number that tells you how to read the rest of the panel.
FitScript scores SHBG against its own sex-specific bands, which are not a lab reference range: for men, FitScript's acceptable band is 10 to 80 nmol/L and its optimal target is 20 to 50; for women, FitScript's acceptable band is 20 to 180 nmol/L and its optimal target is 40 to 120. Each lab sets its own reference range, so compare your result against the range printed on your own lab report.
| FitScript band | Men (nmol/L) | Women (nmol/L) |
|---|---|---|
| FitScript acceptable band | 10 to 80 | 20 to 180 |
| FitScript optimal target | 20 to 50 | 40 to 120 |
Reference ranges vary by lab, age and sex, so read your own result against the range printed on your own report rather than against a range from an article. FitScript's optimal ranges are optimization targets, not diagnostic cut-offs, and a value outside them is information to discuss rather than a verdict.
Two details explain why the women's optimal band sits higher. Estrogen exposure drives SHBG production upward, and oral estrogen in particular passes through the liver before reaching the circulation, so women generally run higher SHBG than men at the same metabolic health. Levels also tend to drift upward with age in men, which is one reason total testosterone can hold steady while free testosterone declines.
A single value is a snapshot. Trend across repeated draws at the same lab tells you far more than one number read in isolation.
A low SHBG result most often reflects a liver responding to high insulin exposure, excess liver fat, or androgen excess, and it is usually a metabolic signal rather than a hormone problem in itself.
The association between low SHBG and insulin resistance is one of the more consistent findings in this area of endocrinology, reported across different populations and study designs[4]. In women, lower SHBG has also been examined in relation to later type 2 diabetes risk, though researchers continue to debate how much of that relationship is causal and how much reflects shared upstream metabolic drivers[5]. Genetics contribute as well, and variants in the SHBG gene have been associated with polycystic ovary syndrome risk in meta-analysis, which means some people sit lower than their lifestyle alone would predict[6].
The honest framing is observation, then meaning, then next step. The observation is a number below the range. The possible meaning is that insulin signalling and liver fat deserve a closer look. The next step is to test the supporting markers and review the whole picture with a clinician rather than treating the SHBG value on its own.
A high SHBG result commonly reflects strong estrogen exposure, thyroid overactivity, liver disease, advancing age, or low energy availability from undereating or very high training volume.
Oral estrogen raises SHBG markedly because of first-pass hepatic exposure, and pregnancy raises it substantially as well. Thyroid hormone is a direct upregulator of SHBG transcription, so overactive thyroid states tend to run high[1].
High SHBG is not automatically a problem. In some reproductive contexts a higher baseline SHBG has been examined as a favourable signal, with research exploring its relationship to ovulation[7]. SHBG has likewise been studied in relation to estradiol exposure and breast cancer biology, where the mechanistic argument is that SHBG restrains free estradiol, although the clinical interpretation of any individual result remains a matter for a clinician[8].
What matters practically is that a high SHBG lowers free testosterone and free estradiol for a given total. If someone has symptoms of low androgen activity alongside a normal total testosterone and a high SHBG, that combination is worth discussing with a clinician rather than dismissing because the total looked fine.
The steps that raise SHBG are the ones that lower insulin exposure and reduce liver fat, applied consistently over months rather than days.
No supplement reliably raises SHBG on its own. The leverage is metabolic.
Insulin resistance lowers SHBG mainly by changing what liver cells are doing, not by binding or clearing SHBG from the blood.
The mechanism that best fits current evidence runs through HNF-4 alpha.[1] When the liver is handling a steady surplus of energy and especially of simple sugars, hepatic de novo lipogenesis increases, HNF-4 alpha activity falls, and transcription of the SHBG gene falls with it[1]. Hepatic fat accumulation appears to be the closer driver than circulating insulin alone, which is why SHBG often tracks liver fat more tightly than it tracks body weight.
That model explains several otherwise confusing observations. It explains why lean people with fatty liver can have low SHBG. It explains why SHBG often rises early in a fat-loss phase, before much weight has moved, as liver fat clears. And it explains the repeatedly documented inverse relationship between SHBG and markers of insulin resistance across study populations[4].
Research has also asked whether SHBG is merely a marker of this process or an active participant in metabolic risk, and the question remains genuinely open, particularly in women[5].
For the reader, the takeaway is directional. Treat a low SHBG as a prompt to examine insulin and liver health, and the hormone number tends to follow.
Eat in a way that lowers the insulin load of your average day and reduces liver fat, because that is the pathway SHBG responds to.
In practice that means a food pattern built on vegetables, legumes, whole fruit, intact grains, fish, eggs, dairy if tolerated, nuts, olive oil and adequate protein, with added sugar and refined flour kept to the edges. Sugar-sweetened drinks and fruit juice deserve particular attention, since fructose delivered in liquid form reaches the liver quickly and supports lipogenesis.
Fibre is the most underrated lever here. It blunts post-meal glucose, supports satiety and is associated with better insulin sensitivity, which is the upstream input SHBG is tracking.
Alcohol belongs in the diet conversation rather than a separate one, because it adds energy and directly promotes hepatic fat accumulation.
Two cautions. Very aggressive restriction can raise SHBG through low energy availability, which is not the same thing as metabolic improvement. And no single food, spice or supplement is established as raising SHBG reliably in humans, so treat confident claims about specific herbs with scepticism.
Yes, in most people fat loss and regular training are associated with a rise in SHBG, and the effect appears to track liver fat and insulin sensitivity rather than scale weight alone.
Resistance training improves glucose uptake into muscle and increases the amount of tissue available to store glucose, both of which lower the insulin exposure the liver sees. Aerobic work, including simple daily walking, improves insulin sensitivity through partly separate mechanisms, so combining the two is more useful than arguing about which is better. Neither has to be elaborate. Consistency over months is what shows up on a retest.
There are two directions where training works against SHBG expectations. Anabolic steroid and high-dose androgen exposure suppresses SHBG strongly, which is one reason very low SHBG alongside a very high total testosterone prompts questions from a clinician. At the other extreme, high training volume combined with chronic underfuelling can raise SHBG as part of a low energy availability picture, usually alongside falling sex hormones and disrupted cycles in women, which is a pattern to discuss with a clinician rather than to pursue.
A rising SHBG during a well-fuelled fat-loss phase is a reasonable sign that liver metabolism is moving in the right direction.
They matter a great deal, because the liver is where SHBG is produced and the state of that tissue sets production capacity.
Non-alcoholic fatty liver is consistently associated with lower SHBG, which is consistent with the lipogenesis and HNF-4 alpha mechanism described above[1]. Reducing liver fat through dietary change, fat loss and exercise is therefore one of the more direct routes to a higher value.
Alcohol complicates the picture because its effect depends on dose and on liver status. Regular heavy intake contributes to hepatic fat and injury, while advanced liver disease is often associated with higher SHBG rather than lower, reflecting disturbed hepatic function and altered sex steroid handling rather than better metabolic health. In other words, a high SHBG is not automatically good news, and context decides.
Worth checking alongside SHBG are liver enzymes such as ALT, AST and GGT, plus triglycerides, since the combination of raised ALT, raised triglycerides and low SHBG points fairly clearly toward hepatic fat as the thing to address.
If liver markers are outside the standard range, that is worth discussing with a clinician promptly rather than managing alone with diet changes.
Both move SHBG strongly, and they move it upward, which is why thyroid and estrogen status have to be considered before concluding that a result reflects metabolic health.
Thyroid hormone is a direct stimulator of hepatic SHBG production, so overactive thyroid states tend to run high and underactive states tend to run low[1]. That makes TSH and free T4 reasonable companions to an SHBG test, particularly when a low value appears in someone who is otherwise metabolically healthy. Thyroid replacement is a prescription matter, and a licensed provider evaluates whether it is appropriate.
Estrogens raise SHBG, and the route of administration matters because oral estrogen passes through the liver before entering the general circulation while transdermal routes largely bypass that first pass. Any decision about starting, changing or stopping hormonal medication belongs with a licensed provider who has reviewed the full clinical picture.
Pregnancy also raises SHBG substantially, so results drawn during pregnancy cannot be compared with pre-pregnancy values.
The influences on SHBG fall into fairly predictable directions, which makes a quick reference useful when reading a result.
| Influence | Usual direction of SHBG |
|---|---|
| Insulin resistance, excess liver fat | Lower |
| Excess central body fat | Lower |
| Exogenous androgens, anabolic steroids | Lower |
| Underactive thyroid | Lower |
| Growth hormone excess | Lower |
| Pregnancy | Higher |
| Overactive thyroid | Higher |
| Chronic liver disease | Higher |
| Low energy availability, prolonged restriction | Higher |
| Advancing age in men | Gradually higher |
This table describes associations reported in the clinical literature, not a formula for predicting an individual result. Several influences often operate at once, which is why interpretation needs the rest of the panel and a clinician's read.
No dosing, schedule or administration guidance for any hormonal or prescription therapy appears here, because those decisions belong to a licensed provider who has evaluated whether a treatment is appropriate for a specific person.
SHBG is measured on a standard blood draw, usually by immunoassay, and the main threats to a reliable result are assay differences between labs and inconsistent draw conditions.
Different SHBG assays do not always agree, and because free testosterone is typically calculated from SHBG rather than measured, that disagreement propagates into the free testosterone figure a report shows[3]. The practical fix is to retest at the same laboratory using the same assay whenever you are tracking change over time, and to be cautious about comparing a value from one provider directly against a value from another.
For consistency, draw in the morning, fasted, and keep sex hormones on the same draw since they are interpreted together. Avoid testing during acute illness. High-dose biotin supplements can interfere with some immunoassays, so tell the lab or your clinician if you take them. Women should note cycle day, since estradiol and testosterone vary across the cycle even though SHBG itself moves comparatively slowly.
Because SHBG shifts over weeks to months rather than days, a retest a day after a dietary change tells you nothing useful. Allow a sustained period of changed behaviour before drawing conclusions from a new number.
SHBG is close to uninterpretable alone, so it should be ordered with the hormone and metabolic markers that explain it.
The hormone side includes total testosterone, free testosterone, estradiol, and in many cases LH and FSH, which help distinguish a testicular or ovarian signal from a central one. The metabolic side matters just as much. Fasting insulin and fasting glucose, HbA1c, triglycerides and HDL, and liver enzymes including ALT, AST and GGT together describe the insulin and liver-fat environment that SHBG is responding to. Thyroid markers round out the picture, since thyroid status is one of the strongest non-metabolic influences on the value.
Read together, these markers usually tell a coherent story. Low SHBG with raised fasting insulin, raised triglycerides and raised ALT points toward hepatic insulin resistance. Low SHBG with a very high total testosterone raises questions about androgen exposure. High SHBG with low free testosterone and a normal total explains symptoms that the total alone would hide.
FitScript's membership is built around repeat testing of this kind, with 150+ biomarkers tested per year, and Atlas, FitScript's AI health advisor, interprets the panel in context so single values are not read in isolation. Any treatment that follows is decided by a licensed provider after reviewing the member.
SHBG changes over weeks to months, so meaningful movement generally follows a sustained period of altered diet, training, alcohol intake or body composition rather than a short experiment.
That timeline comes from the biology. SHBG production responds to the liver's metabolic state, and hepatic fat and insulin sensitivity shift gradually. Retesting after a consistent block of change at the same laboratory gives a fairer read than frequent testing, and the trend across two or three draws carries more information than any single value.
Talk to a clinician if your result sits outside the standard laboratory range, if it is suboptimal alongside symptoms such as low libido, poor recovery, fatigue, irregular cycles or unexplained changes in body composition, or if liver enzymes, glucose markers or thyroid markers are also outside range. Discuss any result promptly rather than waiting if symptoms are significant or worsening. Never ignore an abnormal result because an article described it as common.
Always discuss your results and any treatment options with a clinician or licensed provider who can see your full history, medications and examination findings. Education narrows the questions worth asking. It does not replace the person who answers them.
For marker-by-marker detail, see the FitScript reference pages for SHBG, testosterone total, testosterone free, estradiol and fasting insulin, or review what is included in the lab panels.
Raise SHBG by lowering insulin exposure and liver fat. That means cutting added sugar and refined starch, eating more fibre, losing excess body fat, training with resistance and daily movement, moderating alcohol, sleeping properly, and having thyroid function checked. Changes show over months, so retest at the same lab.
The effective route is metabolic rather than supplemental. Improve insulin sensitivity, reduce hepatic fat, and address anything suppressing production such as untreated low thyroid function or androgen exposure. Review medications with a licensed provider, then retest SHBG alongside testosterone, estradiol and fasting insulin after a sustained period of change.
Target the inputs SHBG responds to in the liver. Lower refined carbohydrate and liquid sugar intake, increase fibre, reduce alcohol, lose excess visceral fat, and train consistently. Correcting an underactive thyroid under clinical care can also help. No supplement is established as a dependable way to raise SHBG.
In men, low SHBG usually tracks insulin resistance, liver fat and central adiposity, so fat loss, resistance training, fibre-rich eating and less alcohol are the main levers. Exogenous androgens suppress SHBG strongly. Discuss any androgen or hormone therapy with a licensed provider, who evaluates whether it is appropriate.
In women, low SHBG is often linked to insulin resistance and androgen excess, including the pattern seen in polycystic ovary syndrome. Improving insulin sensitivity through diet, fat loss and training is the main lever. Oral estrogen raises SHBG markedly, but any hormonal medication decision belongs with a licensed provider.
Low SHBG is most often associated with insulin resistance, excess liver fat and central obesity, which reduce SHBG production in liver cells. Other contributors include exogenous androgens or anabolic steroids, glucocorticoid exposure, an underactive thyroid and genetic variation in the SHBG gene. Interpretation needs the full panel.
Estrogen exposure, especially oral estrogen, raises SHBG through first-pass liver effects, as does pregnancy. Thyroid hormone directly stimulates production, so overactive thyroid states run high.
SHBG shifts over weeks to months rather than days, because it tracks liver fat and insulin sensitivity, which change gradually. Retest after a sustained block of altered diet, training and alcohol intake, using the same laboratory and assay, and judge the trend across draws rather than one value.